Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C

Autor: Carmen Elena, Gómez, Beatriz, Perdiguero, Victoria, Jiménez, Abdelali, Filali-Mouhim, Khader, Ghneim, Elias K, Haddad, Esther D, Quakkelaar, Esther D, Quakkerlaar, Julie, Delaloye, Alexandre, Harari, Thierry, Roger, Thomas, Duhen, Thomas, Dunhen, Rafick P, Sékaly, Cornelis J M, Melief, Thierry, Calandra, Federica, Sallusto, Antonio, Lanzavecchia, Ralf, Wagner, Giuseppe, Pantaleo, Mariano, Esteban

Publikováno v: Retrovirology
PLoS ONE, 7 (4)
PLoS ONE, 7(4)
Plos One, vol. 7, no. 4, pp. e35485
PloS one
Retrovirology, Vol 9, Iss Suppl 2, p P303 (2012)
PLoS ONE, Vol 7, Iss 4, p e35485 (2012)
PLoS ONE

Based on the partial efficacy of the HIV/AIDS Thai trial (RV144) with a canarypox vector prime and protein boost, attenuated poxvirus recombinants expressing HIV-1 antigens are increasingly sought as vaccine candidates against HIV/AIDS. Here we descr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85e8bb3e5ff4917c2186369798e785d6
http://europepmc.org/articles/PMC3441266